Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| AXSOME THERAPEUTICS | 19 | 1 | +0,74 % | ||
| VANDA PHARMACEUTICALS | 13 | - | +0,81 % | ||
| ULTRAGENYX | 6 | - | +1,76 % | ||
| BIONTECH | 4 | 13 | -0,06 % | ||
| ALKERMES | 2 | 8 | -1,67 % | ||
| ZYMEWORKS | 2 | 5 | +0,88 % | ||
| ASCENDIS PHARMA | 2 | - | -0,56 % | ||
| COGENT BIOSCIENCES | 2 | - | -2,83 % | ||
| PRAXIS PRECISION MEDICINES | 2 | - | -0,43 % | ||
| ATAI BECKLEY | 2 | - | +0,36 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20:22 | FDA-Entscheidung beflügelt Axsome-Aktie: Beschleunigte Prüfung für Alzheimer-Medikament | 1 | Investing.com Deutsch | ||
| 20:10 | Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months | 3 | Zacks | ||
| 19:54 | Oppenheimer raises Axsome Therapeutics stock price target to $220 on FDA news | 1 | Investing.com | ||
| 19:46 | Axsome Therapeutics: Oppenheimer erhöht Kursziel nach FDA-Entscheidung auf 220 $ | 2 | Investing.com Deutsch | ||
| 19:30 | Morgan Stanley reiterates Overweight rating on Axsome stock with $196 target | 1 | Investing.com | ||
| 19:22 | Morgan Stanley bestätigt 'Overweight'-Rating für Axsome nach FDA-Meilenstein | 2 | Investing.com Deutsch | ||
| 19:01 | Why Axsome Therapeutics Stock Rocketed Higher to End 2025 | 1 | The Motley Fool | ||
| 18:45 | Axsome Therapeutics Stock Jumps After FDA Grants Priority Review For Alzheimer's Agitation Drug | 2 | Investor's Business Daily | ||
| 18:06 | Ultragenyx completes rolling FDA submission for US approval of gene therapy | 3 | Seeking Alpha | ||
| 17:59 | Axsome Shares Jump 19% After FDA Acceptance Of AX-S12 Priority Review And Positive Pre-NDA Feedback | 1 | RTTNews | ||
| 16:58 | Vanda ends 40-year hiatus for new motion sickness drugs | 4 | pharmaphorum | ||
| 16:54 | What's Going On With Royalty Pharma Stock Wednesday? | 1 | Benzinga.com | ||
| 16:42 | Ultragenyx Pharma stock rating reiterated at Outperform by Leerink | 2 | Investing.com | ||
| 16:42 | FDA Fast-Tracks Axsome's Alzheimer's Agitation Drug, Stock Soars | 2 | Benzinga.com | ||
| 16:38 | Eilmeldung am Abend: BIONTECH SE ADR zieht Aufmerksamkeit | 10 | Maximilian Berger | ||
| 16:30 | Biontech-Aktie mit auffälligem Momentum: Investoren beobachten nervös - nicht verpassen! | Hebelschein-Spekulant | |||
| 15:42 | Axsome Therapeutics stock holds Buy rating at Truist on AXS-05 sNDA acceptance | 3 | Investing.com | ||
| 15:42 | Jefferies reiterates Buy rating on Xeris Pharmaceuticals stock amid competitor setback | 2 | Investing.com | ||
| 15:26 | Strong Momentum Lifted BeOne Medicines AG (ONC) in Q3 | 2 | Insider Monkey | ||
| 15:26 | Here's Why Genmab A/S (GMAB) Rose in Q3 | 2 | Insider Monkey |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .